(Q44795662)

6 December 2017

title

Dendritic cells become BCR-ABL negative in chronic myeloid leukaemia patients successfully treated with imatinib (English)

1 reference

6 December 2017

1 reference

Wang L

1

1 reference

6 December 2017

Butt NM

series ordinal

2

1 reference

6 December 2017

Atherton MG

series ordinal

3

1 reference

6 December 2017

Clark RE

series ordinal

4

1 reference

6 December 2017

publication date

1 May 2004

1 reference

6 December 2017

number of pages

3

1 reference

inferred from page(s)

published in

Leukemia

1 reference

6 December 2017

volume

18

1 reference

6 December 2017

issue

5

1 reference

6 December 2017

page(s)

1025-1027

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.leu.2403342

6 December 2017

exact match

0 references

cites work

Direct evidence that leukemic cells present HLA-associated immunogenic peptides derived from the BCR-ABL b3a2 fusion protein

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403342

Dendritic cells generated from blood precursors of chronic myelogenous leukemia patients carry the Philadelphia translocation and can induce a CML-specific primary cytotoxic T-cell response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403342

Alloreactive CD4+ T lymphocytes can exert cytotoxicity to chronic myeloid leukaemia cells processing and presenting exogenous antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403342

Dendritic cells from CML patients have altered actin organization, reduced antigen processing, and impaired migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403342

Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403342

Serial monitoring of BCR-ABL by peripheral blood real-time polymerase chain reaction predicts the marrow cytogenetic response to imatinib mesylate in chronic myeloid leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403342

Imatinib and plasmacytoid dendritic cell function in patients with chronic myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403342

Clonal heterogeneity of dendritic cells derived from patients with chronic myeloid leukemia and enhancement of their T-cells stimulatory activity by IFN-α

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403342

Generation of dendritic cells expressing bcr-abl from CD34-positive chronic myeloid leukemia precursor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403342

7 January 2021

inferred from DOI database lookup

Rapid establishment of dendritic cell chimerism in allogeneic hematopoietic cell transplant recipients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403342

7 January 2021

inferred from DOI database lookup

Optimizing preparation of normal dendritic cells and bcr-abl+ mature dendritic cells derived from immunomagnetically purified CD14+ cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403342

7 January 2021

inferred from DOI database lookup

Identifiers

DOI

10.1038/SJ.LEU.2403342

1 reference

6 December 2017

1 reference